Application | Comment | Organism |
---|---|---|
drug development | elucidation of the mechanisms responsible for aberrant phosphatidylcholine metabolism in cancer cells may allow identification of novel biomarkers of tumor progression and design of new targeted anticancer therapies | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
tricyclodecan-9-yl-potassium xanthate | The recovery of both variables to their original levels in serum-restimulated (or lysophosphatidic acid-restimulated) EOC cells is strongly delayed, for at least 24 h, in the presence of the PC-PLC inhibitor tricyclodecan-9-yl-potassium xanthate (D609). The S-phase of serum-restimulated EONT cells is not sensitive to D609 | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytoplasm | - |
Homo sapiens | 5737 | - |
nucleus | - |
Homo sapiens | 5634 | - |
plasma membrane | of cancer cells | Homo sapiens | 5886 | - |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
66000 | - |
Western blot analysis | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
EONT cell | nontumoral (normal or immortalized) counterparts (EONT) | Homo sapiens | - |
epithelial ovarian cancer cell | different cell lines of epithelial ovarian cancer cells (EOC) compared with nontumoral (normal or immortalized) counterparts (EONT) | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
phosphatidylcholine + H2O | - |
Homo sapiens | 1,2-diacylglycerol + phosphorylcholine | - |
? |
Synonyms | Comment | Organism |
---|---|---|
PC-PLC | - |
Homo sapiens |
phosphatidylcholine-specific phospholipase C | - |
Homo sapiens |
phospholipase C | - |
Homo sapiens |